Article

Clinical Trials: Rabeprazole for Treatment of GERD in Pediatric Patients

The researchers conducting this study seek to assess "the effectiveness and safety of oral rabeprazole in the treatment of acid-related disorders in pediatric patients."

Interventional

Study Type:

1-11 years (male/female)

Age/Gender Requirement:

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Sponsor:

The researchers conducting this study seek to assess “the effectiveness and safety of oral rabeprazole in the treatment of acid-related disorders in pediatric patients, focusing specifically on the manifestation of GERD (symptomatic and erosive types).”

To access this third-party resource, click here.

Purpose:

Rabeprazole for Treatment of GERD in Pediatric Patients

Related Videos
Jessica Crimaldi, NP | Credit: Jessica Crimaldi on LinkedIn
Andrea Banty, NP, DNP
Lisa Richards, MSN, FNP-BC | Credit: UC San Diego
Nicole Martinez de Andino, NP | Credit: Wellstar MCG Health
Taha Qazi, MD | Credit: Cleveland Clinic
Taha Qazi, MD | Credit: Cleveland Clinic
William Grady, MD | Credit: Fred Hutchinson Cancer Center
Edward V Loftus, Jr, MD | Credit: Mayo Clinic
Taha Qazi, MD | Credit: Cleveland Clinic
© 2024 MJH Life Sciences

All rights reserved.